BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33908669)

  • 1. Elevated GFAP isoform expression promotes protein aggregation and compromises astrocyte function.
    Lin NH; Yang AW; Chang CH; Perng MD
    FASEB J; 2021 May; 35(5):e21614. PubMed ID: 33908669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease.
    Sosunov AA; McKhann GM; Goldman JE
    Acta Neuropathol Commun; 2017 Mar; 5(1):27. PubMed ID: 28359321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease.
    Pekny T; Faiz M; Wilhelmsson U; Curtis MA; Matej R; Skalli O; Pekny M
    APMIS; 2014 Jan; 122(1):76-80. PubMed ID: 23594359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease.
    Hagemann TL; Boelens WC; Wawrousek EF; Messing A
    Hum Mol Genet; 2009 Apr; 18(7):1190-9. PubMed ID: 19129171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease.
    Tian R; Gregor M; Wiche G; Goldman JE
    Am J Pathol; 2006 Mar; 168(3):888-97. PubMed ID: 16507904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander Disease.
    Hagemann TL; Coyne S; Levin A; Wang L; Feany MB; Messing A
    Cells; 2023 Mar; 12(7):. PubMed ID: 37048051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response.
    Hagemann TL; Connor JX; Messing A
    J Neurosci; 2006 Oct; 26(43):11162-73. PubMed ID: 17065456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.
    Minkel HR; Anwer TZ; Arps KM; Brenner M; Olsen ML
    Glia; 2015 Dec; 63(12):2285-97. PubMed ID: 26190408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27.
    Der Perng M; Su M; Wen SF; Li R; Gibbon T; Prescott AR; Brenner M; Quinlan RA
    Am J Hum Genet; 2006 Aug; 79(2):197-213. PubMed ID: 16826512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic conversions of "protoplasmic" to "reactive" astrocytes in Alexander disease.
    Sosunov AA; Guilfoyle E; Wu X; McKhann GM; Goldman JE
    J Neurosci; 2013 Apr; 33(17):7439-50. PubMed ID: 23616550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant astrocyte Ca
    Saito K; Shigetomi E; Yasuda R; Sato R; Nakano M; Tashiro K; Tanaka KF; Ikenaka K; Mikoshiba K; Mizuta I; Yoshida T; Nakagawa M; Mizuno T; Koizumi S
    Glia; 2018 May; 66(5):1053-1067. PubMed ID: 29383757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial fibrillary acidic protein exhibits altered turnover kinetics in a mouse model of Alexander disease.
    Moody LR; Barrett-Wilt GA; Sussman MR; Messing A
    J Biol Chem; 2017 Apr; 292(14):5814-5824. PubMed ID: 28223355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease.
    Mignot C; Delarasse C; Escaich S; Della Gaspera B; NoƩ E; Colucci-Guyon E; Babinet C; Pekny M; Vicart P; Boespflug-Tanguy O; Dautigny A; Rodriguez D; Pham-Dinh D
    Exp Cell Res; 2007 Aug; 313(13):2766-79. PubMed ID: 17604020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in GFAP Disrupt the Distribution and Function of Organelles in Human Astrocytes.
    Jones JR; Kong L; Hanna MG; Hoffman B; Krencik R; Bradley R; Hagemann T; Choi J; Doers M; Dubovis M; Sherafat MA; Bhattacharyya A; Kendziorski C; Audhya A; Messing A; Zhang SC
    Cell Rep; 2018 Oct; 25(4):947-958.e4. PubMed ID: 30355500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity.
    Battaglia RA; Beltran AS; Delic S; Dumitru R; Robinson JA; Kabiraj P; Herring LE; Madden VJ; Ravinder N; Willems E; Newman RA; Quinlan RA; Goldman JE; Perng MD; Inagaki M; Snider NT
    Elife; 2019 Nov; 8():. PubMed ID: 31682229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
    Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
    Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Enzyme Alterations and Astrocyte Dysfunction in a Murine Model of Alexander Disease With Severe Reactive Gliosis.
    Heaven MR; Herren AW; Flint DL; Pacheco NL; Li J; Tang A; Khan F; Goldman JE; Phinney BS; Olsen ML
    Mol Cell Proteomics; 2022 Jan; 21(1):100180. PubMed ID: 34808356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial fibrillary acidic protein filaments can tolerate the incorporation of assembly-compromised GFAP-delta, but with consequences for filament organization and alphaB-crystallin association.
    Perng MD; Wen SF; Gibbon T; Middeldorp J; Sluijs J; Hol EM; Quinlan RA
    Mol Biol Cell; 2008 Oct; 19(10):4521-33. PubMed ID: 18685083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregation-prone GFAP mutation in Alexander disease validated using a zebrafish model.
    Lee SH; Nam TS; Kim KH; Kim JH; Yoon W; Heo SH; Kim MJ; Shin BA; Perng MD; Choy HE; Jo J; Kim MK; Choi SY
    BMC Neurol; 2017 Sep; 17(1):175. PubMed ID: 28882119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia sense astrocyte dysfunction and prevent disease progression in an Alexander disease model.
    Saito K; Shigetomi E; Shinozaki Y; Kobayashi K; Parajuli B; Kubota Y; Sakai K; Miyakawa M; Horiuchi H; Nabekura J; Koizumi S
    Brain; 2024 Feb; 147(2):698-716. PubMed ID: 37955589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.